Not suitable for use during pregnancy & lactation
#85 Zone 2 Training and Metabolic Health Guest Episode Ep

[4] [5] Appropriate clinical management for patients with comorbid metabolic conditions and problematic alcohol use should include: Comprehensive assessment of alcohol consumption patterns using validated screening tools (AUDIT, AUDIT-C) Referral to addiction medicine specialists or behavioral health providers for evidence-based AUD treatment, especially with red flags such as history of severe withdrawal, seizures, delirium tremens, pregnancy, severe liver disease, or suicidality Consideration of FDA-approved pharmacotherapies for alcohol use disorder (naltrexone, acamprosate, disulfiram) with attention to their specific contraindications [9] [11] If GLP-1 therapy is indicated for diabetes or obesity, close monitoring for changes in alcohol consumption and related behaviors Patient education emphasizing that any effects on alcohol cravings are not established therapeutic benefits Regular follow-up to assess medication adherence, adverse effects, and overall treatment response Patients should never discontinue evidence-based treatments for alcohol use disorder in favor of unproven approaches

When body mass index (BMI) is high, it indicates that the body weight is more than what is considered healthy for a given height
The fundamental mechanisms are similar enough that management approaches transfer directly
News Release February 26, 2026 ConsumerLab Survey Shows Growth in Creatine and Magnesium Supplements White Plains, New York, February 26, 2026 A recent survey of more than 8,850 people who regularly use dietary supplements shows that, among the 200 most popular supplements, creatine led in growth (+17